Proteus Digital Health Announces FDA Clearance of Ingestible Sensor

Proteus Digital Health, Inc. announced today that the U.S. Food and Drug Administration (FDA) has cleared its ingestible sensor for marketing as a medical device.

Read more

Posted in Type I Type II Glucose & Insulin